Clinical Diagnostics Market Research Reports & Consulting

Market Reports

• Blood Culture Tests Market by Method (Automated, Conventional), Product (Consumable, Media, Instruments), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Mycobacterial), End User (Hospital, Academic Research) - Global Forecast to 2025

  The Blood Culture Tests Market is expected to grow from USD 4.0 billion in 2020 to USD 6.1 billion by 2025, at a CAGR of 8.9% during the forecast period. Major players operating in the blood culture tests market include Becton, Dickinson and Company (US), Thermo Fisher Scientific, Inc. (US), bioMérieux SA (France), Luminex Corporation (US), Danaher Corporation (US), Bruker Corporation (US), IRIDICA (US), Roche Diagnostics (Switzerland), T2 Biosystems, Inc. (US), Anaerobe Systems, Inc. (US), OpGen, Inc. (US), Meditech Technologies India Private Limited (India), Carl Zeiss AG (Germany), Nikon Corporation (Japan), BINDER GmbH (Germany), Biobase Biotech (Jinan) Co., Ltd. (China), Scenker Biological Technology Co., Ltd. (China), Bulldog Bio, Inc. (US), Axiom Laboratories (India), and HiMedia Laboratories Pvt. Ltd. (India).

  • Published: February 2021
  • Price: $ 4950
  • TOC Available:

• Biochips Market Size & Share by Type (DNA Chip (Genomics, Drug Discovery, Gene Expression) Lab-on-a-chip (IVD & POC, Proteomics), Protein Chips), Fabrication Technology (Microarrays, Microfluidics), End user (Academics Institutes, Diagnostics Centers) - Global Forecast to 2020

  is 2015 and the forecast for the market size is provided for the period between 2015 and 2020. In the current market scenario, biochips are increasingly adopted in various applications in the field of genomics, drug discovery, and proteomics. In addition, the development of targeted and personalized medicines for the treatment of cancer and technological advancements in biochips are also supporting the growth of biochip products.

  • Published: May 2016
  • Price: $ 4950
  • TOC Available:

• Global Clinical Trials Market (Key Therapeutic Categories, Country Wise Metrics & Regulatory Approval Framework)

  This research report categorizes the Global Clinical Trials Market on the basis of phases, indications, and study design analyzing trends in each. Each section will provide market data, market drivers, trends and opportunities, key players, and competitive outlook. This report will also provide more than 20 company profiles.

  • Published: September 2011
  • Price: $ 4950
  • TOC Available:

• US Neonatal (Preterm) Infant Care Market (2010-2015)

  Preterm infant care forms a significant part of the pediatric healthcare market in U.S as preterm births are on a alarming rise in the nation. Preterm births are one of the leading causes of infant mortality in U.S with 1 in 8 births being preterm. Induced fertility and labor treatments, poor prenatal care, inappropriate maternal age, obesity, smoking are some of the major reasons responsible for increasing incidence of preterm births in the country. Preterm infant care products such as infant care devices, infant formula and drugs face a great demand in United States due to the absolute necessity of such products in sustaining baby lives. The products are indispensable in saving preterm babies because they are biologically immature and require external medical assistance in the form of respiratory, nutritional and thermal control support for survival. Infant care products have helped to increase the survival of preterm babies in the country. The criticality of the products in preterm infant care is driving the market. Furthermore, technology advances in regards to multi function equipments are also propelling the growth of the market.

  • Published: March 2011
  • Price: $ 4950
  • TOC Available: